BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37545598)

  • 1. Design, synthesis, anti-proliferative evaluation, docking, and MD simulation studies of new thieno[2,3-
    El-Metwally SA; Elkady H; Hagras M; Husein DZ; Ibrahim IM; Taghour MS; El-Mahdy HA; Ismail A; Alsfouk BA; Elkaeed EB; Metwaly AM; Eissa IH
    RSC Adv; 2023 Jul; 13(33):23365-23385. PubMed ID: 37545598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2.
    El-Metwally SA; Abuelkhir AA; Elkady H; Taghour MS; Ibrahim IM; Husein DZ; Alsfouk AA; Sultan A; Ismail A; Elkhawaga SY; Elkaeed EB; Metwaly AM; Eissa IH
    Comput Biol Chem; 2023 Oct; 106():107928. PubMed ID: 37480629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies.
    Sobh EA; Dahab M; Elkaeed E; Alsfouk B; Ibrahim I; Metwaly AM; Eissa I
    Med Chem; 2024 May; ():. PubMed ID: 38798211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies.
    Elkady H; Abuelkhir AA; Rashed M; Taghour MS; Dahab MA; Mahdy HA; Elwan A; Al-Ghulikah HA; Elkaeed EB; Ibrahim IM; Husein DZ; Metwaly A; Eissa IH
    Comput Biol Chem; 2023 Dec; 107():107958. PubMed ID: 37714080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors.
    Elkady H; El-Dardir OA; Elwan A; Taghour MS; Mahdy HA; Dahab MA; Elkaeed EB; Alsfouk BA; Ibrahim IM; Husein DZ; Hafez EE; Darwish AMG; Metwaly AM; Eissa IH
    RSC Adv; 2023 Sep; 13(40):27801-27827. PubMed ID: 37731835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of thieno[2,3-d]pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents.
    El-Metwally SA; Abou-El-Regal MM; Eissa IH; Mehany ABM; Mahdy HA; Elkady H; Elwan A; Elkaeed EB
    Bioorg Chem; 2021 Jul; 112():104947. PubMed ID: 33964580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors:
    Eissa IH; Elkady H; Rashed M; Elwan A; Hagras M; Dahab MA; Taghour MS; Ibrahim IM; Husein DZ; Elkaeed EB; Al-Ghulikah HA; Metwaly AM; Mahdy HA
    Heliyon; 2024 Jan; 10(2):e24005. PubMed ID: 38298627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel thieno[2,3-d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor-2: A story of computer-aided drug discovery.
    Sobh EA; Dahab MA; Elkaeed EB; Alsfouk BA; Ibrahim IM; Metwaly AM; Eissa IH
    Drug Dev Res; 2023 Sep; 84(6):1247-1265. PubMed ID: 37232504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-
    El-Metwally SA; Elkady H; Hagras M; Elkaeed EB; Alsfouk BA; Doghish AS; Ibrahim IM; Taghour MS; Husein DZ; Metwaly AM; Eissa IH
    Future Med Chem; 2023 Nov; 15(22):2065-2086. PubMed ID: 37955128
    [No Abstract]   [Full Text] [Related]  

  • 10. Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2.
    Yousef RG; Eldehna WM; Elwan A; Abdelaziz AS; Mehany ABM; Gobaara IMM; Alsfouk BA; Elkaeed EB; Metwaly AM; Eissa IH
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and
    Elgammal WE; Elkady H; Mahdy HA; Husein DZ; Alsfouk AA; Alsfouk BA; Ibrahim IM; Elkaeed EB; Metwaly AM; Eissa IH
    RSC Adv; 2023 Dec; 13(51):35853-35876. PubMed ID: 38116168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.
    Alanazi MM; Mahdy HA; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Dahab MA; Eissa IH
    Bioorg Chem; 2021 Jul; 112():104949. PubMed ID: 34023640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition, apoptosis induction, and migration suppression.
    Eissa IH; Yousef RG; Sami M; Elkaeed EB; Alsfouk BA; Ibrahim IM; Husein DZ; Elkady H; Metwaly AM
    Pathol Res Pract; 2023 Dec; 252():154924. PubMed ID: 37956639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: design, synthesis, and
    Alanazi MM; Alaa E; Alsaif NA; Obaidullah AJ; Alkahtani HM; Al-Mehizia AA; Alsubaie SM; Taghour MS; Eissa IH
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1732-1750. PubMed ID: 34325596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of new theobromine-based derivatives as potent VEGFR-2 inhibitors: design, semi-synthesis, biological evaluation, and
    Eissa IH; Yousef RG; Elkady H; Elkaeed EB; Alsfouk AA; Husein DZ; Ibrahim IM; Elhendawy MA; Godfrey M; Metwaly AM
    RSC Adv; 2023 Jul; 13(33):23285-23307. PubMed ID: 37538515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide Analogue.
    Eissa IH; Elkaeed EB; Elkady H; Yousef RG; Alsfouk BA; Elzahabi HSA; Ibrahim IM; Metwaly AM; Husein DZ
    Curr Pharm Des; 2023; 29(36):2902-2920. PubMed ID: 38031271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis, Molecular Modeling, and Anticancer Evaluation of New VEGFR-2 Inhibitors Based on the Indolin-2-One Scaffold.
    Abdelgawad MA; Hayallah AM; Bukhari SNA; Musa A; Elmowafy M; Abdel-Rahman HM; Abd El-Gaber MK
    Pharmaceuticals (Basel); 2022 Nov; 15(11):. PubMed ID: 36422546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.